BTAI Competitors & Alternatives

Compare BioXcel Therapeutics Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

BTAI

Main Stock
$1.31
Tradestie Score
58
Market Cap
$50.49M
Revenue Growth
0.2%
Analyst Upside
+968.7%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
CRON Cronos Group Inc. Common Share
$2.71
$1.02B - 55 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.99
$711.32M - 63 Compare
ESPR Esperion Therapeutics, Inc.
$3.15
$584.71M - 58 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$33.98
$543.32M - 63 Compare
ALLO Allogene Therapeutics, Inc. Common Stock
$2.05
$275.13M - 58 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$3.91
$237.15M 6.2 55 Compare
BIOA BioAge Labs, Inc. Common Stock
$22.83
$212.23M - 57 Compare
ATRA Atara Biotherapeutics, Inc
$10.55
$101.48M - 60 Compare
KPTI Karyopharm Therapeutics Inc.
$9.12
$53.85M - 55 Compare
KYNB KYNB
$6.94
- - 60 Compare

Data updated: Jun 24, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry